Patents by Inventor Bo Mollstam

Bo Mollstam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of lactic acid bacteria for improving food lysine absorption of pet animals
    Patent number: 8496924
    Abstract: This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: July 30, 2013
    Assignee: Biogala AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and Use of Lactic Acid Bacteria for Reducing Dental Caries and Bacteria Causing Dental Caries
    Publication number: 20130121932
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: November 5, 2012
    Publication date: May 16, 2013
    Inventors: Bo Mollstam, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Patent number: 8343483
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: January 1, 2013
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Eamonn Connolly
  • Use of selected lactic acid bacteria for reducing infantile colic
    Publication number: 20120121564
    Abstract: The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: January 23, 2012
    Publication date: May 17, 2012
    Applicant: BIOGAIA AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Stabilized bacterial formulation
    Patent number: 8114397
    Abstract: Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause and thereby the amount of TGF-beta-2 in the milk, thus resulting in reduced risk for the lactating mother to develop mastitis.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: February 14, 2012
    Assignee: Biogaia AB
    Inventors: Bengt Bjorksten, Bo Mollstam
  • Immunomodulatory properties of lactobacillus strains
    Publication number: 20110293710
    Abstract: A specific method is provided of improving immunomodulatory properties of Lactobacillus strains using growth media with a specific primary carbon source, including a method of increasing the anti-inflammatory effect of non-pathogenic anti-inflammatory bacterial strains, by the use of specific growth conditions.
    Type: Application
    Filed: February 1, 2011
    Publication date: December 1, 2011
    Inventors: Delphine Saulnier, James Versalovic, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing inflammation caused by
    Patent number: 7960137
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Grant
    Filed: January 25, 2010
    Date of Patent: June 14, 2011
    Assignee: Biogala AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Method for improved breast milk feeding to reduce the risk of allergy
    Patent number: 7955834
    Abstract: Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause and thereby the amount of TGF-beta-2 in the milk, thus resulting in reduced risk for the lactating mother to develop mastitis.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: June 7, 2011
    Assignee: Biogaia AB
    Inventors: Bengt Bjorksten, Bo Mollstam, Elisabeth Sjoberg
  • Use of lactic acid bacteria for improving food lysine absorption of pet animals
    Publication number: 20110086126
    Abstract: This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals.
    Type: Application
    Filed: November 16, 2010
    Publication date: April 14, 2011
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of selected lactic acid bacteria for reducing atherosclerosis
    Publication number: 20110081328
    Abstract: Strains of lactic acid bacteria selected for their capability of increasing the BSH-activity and consequently lowering serum LDL-cholesterol, and simultaneously decreasing the pro-inflammatory cytokine TNF-? levels, for prophylaxis and/or treatment of atherosclerosis and other cardiovascular diseases, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: November 18, 2010
    Publication date: April 7, 2011
    Inventors: Peter Rothschild, Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for improving food lysine absorption of pet animals
    Patent number: 7910127
    Abstract: This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: March 22, 2011
    Assignee: Biogaia AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Stabilized bacterial formulation
    Publication number: 20100129336
    Abstract: Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause and thereby the amount of TGF-beta-2 in the milk, thus resulting in reduced risk for the lactating mother to develop mastitis.
    Type: Application
    Filed: November 5, 2009
    Publication date: May 27, 2010
    Inventors: Bengt Bjorksten, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
    Publication number: 20100129337
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: January 25, 2010
    Publication date: May 27, 2010
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing inflammation caused by
    Patent number: 7678553
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: March 16, 2010
    Assignee: Biogaia AB
    Inventors: Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
    Publication number: 20090238774
    Abstract: The invention herein relates to the use of nonpathogenic, anti-inflammatory and anti-bleeding lactic acid bacteria strains, and products and methods using such strains for treatment and prophylaxis of bleeding gum and gingivitis caused by oral inflammation.
    Type: Application
    Filed: April 2, 2009
    Publication date: September 24, 2009
    Inventors: EAMONN CONNOLLY, BO MOLLSTAM
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Publication number: 20090123394
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Application
    Filed: October 15, 2008
    Publication date: May 14, 2009
    Inventors: Bo Mollstam, Eamonn Connolly
  • Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter
    Publication number: 20090110670
    Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
    Type: Application
    Filed: December 3, 2008
    Publication date: April 30, 2009
    Inventors: Eamonn Connolly, Bo Mollstam
  • Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
    Patent number: 7517681
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: April 14, 2009
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Eamonn Connolly
  • Use of selected lactic acid bacteria for reducing atherosclerosis
    Publication number: 20080254011
    Abstract: Strains of lactic acid bacteria selected for their capability of increasing the BSH-activity and consequently lowering serum LDL-cholesterol, and simultaneously decreasing the pro-inflammatory cytokine TNF-? levels, for prophylaxis and/or treatment of atherosclerosis and other cardiovascular diseases, a method of selecting such strains, and products containing such strains.
    Type: Application
    Filed: April 11, 2007
    Publication date: October 16, 2008
    Inventors: Peter Rothschild, Eamonn Connolly, Bo Mollstam
  • Use of lactic acid bacteria for improving food lysine absorption of pet animals
    Publication number: 20080213431
    Abstract: This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals.
    Type: Application
    Filed: February 26, 2008
    Publication date: September 4, 2008
    Inventors: Eamonn Connolly, Bo Mollstam